Bicycle therapeutics to participate in the jefferies healthcare conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq:bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the jefferies healthcare conference in new york, ny on june 7th, 2023 at 10:30 a.m. et. a live webcast of the fireside chat will be accessible in the investors & media section of bicycle's we.
BCYC Ratings Summary
BCYC Quant Ranking